Michael Zinda, EVP, Chief Scientific Officer: Repare Therapeutics RPTX Sell · Filed 25/03/14

Trade details

Type: Insider sale
Amount: $6,396.54
Shares · price: 5,611 sh · $1.14 a share
Held after: 80,297 sh
Stock: Repare Therapeutics RPTX
Person: Michael ZindaEVP, Chief Scientific Officer
Trade date: 25/03/12
Filed: 25/03/14
Days to filing: 2 days

Sold 6.5% of holdings

Share of holding sold: 6.5%

Repare Therapeutics trades, last 26 weeks

What else happened in Repare Therapeutics around then

Filed or reported within 30 days of the trade day · 25/02/10~25/04/11

Michael Zinda's recent trades

Michael ZindaEVP, Chief Scientific Officer
Sell10b5-1 planRepare Therapeutics
Sell10b5-1 plan
Repare Therapeutics
RPTX
$2,088
450 sh
$2,088
Filed 24/04/01
Traded 24/03/28
Michael ZindaEVP, Chief Scientific Officer
Sell10b5-1 planRepare Therapeutics
Sell10b5-1 plan
Repare Therapeutics
RPTX
$1,911
410 sh
$1,911
Filed 24/04/01
Traded 24/04/01
Michael ZindaEVP, Chief Scientific Officer
Sell10b5-1 planRepare Therapeutics
Sell10b5-1 plan
Repare Therapeutics
RPTX
$2,151
450 sh
$2,151
Filed 24/03/27
Traded 24/03/25
Michael ZindaEVP, Chief Scientific Officer
Sell10b5-1 planRepare Therapeutics
Sell10b5-1 plan
Repare Therapeutics
RPTX
$2,075
450 sh
$2,075
Filed 24/03/27
Traded 24/03/26
Michael ZindaEVP, Chief Scientific Officer
Sell10b5-1 planRepare Therapeutics
Sell10b5-1 plan
Repare Therapeutics
RPTX
$2,079
450 sh
$2,079
Filed 24/03/27
Traded 24/03/27